Malignant neoplasm of left testis, unspecified whether descended or undescended
- C62.92 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- Short description: Malig neoplasm of left testis, unsp descended or undescended
- The 2024 edition of ICD-10-CM C62.92 became effective on October 1, 2023.
- This is the American ICD-10-CM version of C62.92 – other international versions of ICD-10 C62.92 may differ.
ICD-10-CM Coding Rules
- C62.92 is applicable to male patients.
The following code(s) above C62.92 contain annotation back-references
that may be applicable to C62.92:
Approximate Synonyms
- Cancer, left testis
- Nonseminomatous germ cell cancer, bilateral testis
- Nonseminomatous germ cell cancer, l testis
- Primary malignant neoplasm of bilateral testes
- Primary malignant neoplasm of left testis
- Primary nonseminomatous germ cell cancer of bilateral testes
- Primary nonseminomatous germ cell cancer of left testis
- Primary seminoma of bilateral testes
- Primary seminoma of left testis
- Seminoma, bilateral testis
- Seminoma, l testis
- Testicular cancer, bilateral testis
ICD-10-CM C62.92 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):
- 715 Other male reproductive system o.r. Procedures for malignancy with cc/mcc
- 716 Other male reproductive system o.r. Procedures for malignancy without cc/mcc
- 722 Malignancy, male reproductive system with mcc
- 723 Malignancy, male reproductive system with cc
- 724 Malignancy, male reproductive system without cc/mcc
Convert C62.92 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change